Skip to main content
Top
Published in: Reproductive Biology and Endocrinology 1/2010

Open Access 01-12-2010 | Methodology

Can egg donor selection be improved? - a pilot study

Authors: Norbert Gleicher, Andrea Weghofer, David H Barad

Published in: Reproductive Biology and Endocrinology | Issue 1/2010

Login to get access

Abstract

Background

Accurate assessments of ovarian reserve (OR) in egg donor candidates are crucial for maximal donor selection. This study assesses whether recently reported new methods of OR assessment by age-specific (as-), rather than non-as (nas-) hormones, follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH), and triple nucleotide (CGG) repeats on the FMR1 (fragile X) gene have the potential of improving egg donor selection.

Methods

Seventy-three consecutive egg donor candidates (candidates), amongst those 21 who reached egg retrieval (donors), were prospectively investigated for as-FSH, as-AMH and number of CGG repeats. Abnormal findings were assessed in candidates and donors and oocyte yields in the latter were statistically associated with abnormal FSH and AMH (>/< 95% CI of as-levels) and with normal/abnormal numbers of CGG repeats (normal range 26-32).

Results

Amongst candidates mean as-AMH was 3.8 +/- 2.8 ng/mL (37.0% normal, 3.0 +/- 0.7 ng/mL; 26.6% low, 1.5 +/- 0.5 ng/mL; and 37.0% high, 5.8 +/- 2.2 ng/mL). AMH among donors was 4.2 +/- 1.7 ng/mL (33.3% normal, 14.3% low, and 52.4% high), yielding 17.8 +/- 7.2 oocytes, 42.9% in normal range (10-15), 9.5% in low (less than or equal to 9) and 47.6.% in high range (16-32). Candidates in 41.9% and donors in 38.1% demonstrated normal CGG counts; the remained were mostly heterozygous abnormal.

Discussion

Prospective assessment of even carefully prescreened candidates and donors still demonstrates shortcomings on both ends of the OR spectrum. Utilization of ovarian reserve testing methods, like as-hormones and CGG repeats on the FMR1 gene have potential of improving candidate selections.
Appendix
Available only for authorised users
Literature
2.
go back to reference Barad DH, Weghofer A, Gleicher N: Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function. Obstet Gynecol. 2007, 109: 1404-1410. 10.1097/01.AOG.0000264065.37661.a0.CrossRefPubMed Barad DH, Weghofer A, Gleicher N: Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function. Obstet Gynecol. 2007, 109: 1404-1410. 10.1097/01.AOG.0000264065.37661.a0.CrossRefPubMed
3.
go back to reference Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y, Tanaka T: High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome. Hum Reprod. 1995, 10: 1962-1967.PubMed Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y, Tanaka T: High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome. Hum Reprod. 1995, 10: 1962-1967.PubMed
4.
go back to reference Tummon I, Gavrilova-Jordan L, Allemand MC, Session D: Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review. Acta Obstet Gynecol Scand. 2005, 84: 611-616.PubMed Tummon I, Gavrilova-Jordan L, Allemand MC, Session D: Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review. Acta Obstet Gynecol Scand. 2005, 84: 611-616.PubMed
5.
go back to reference Barad DH, Weghofer A, Gleicher N: Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function. Fertil Steril. 2009, 91: 1553-1555. 10.1016/j.fertnstert.2008.09.069.CrossRefPubMed Barad DH, Weghofer A, Gleicher N: Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function. Fertil Steril. 2009, 91: 1553-1555. 10.1016/j.fertnstert.2008.09.069.CrossRefPubMed
6.
go back to reference Gnoth C, Schuring AN, Friol K, Tiggens J, Mallmann P, Godehardt E: Relevance of anti-Müllerian hormone measurement in routine IVF program. Hum Reprod. 2008, 23: 1359-1365. 10.1093/humrep/den108.CrossRefPubMed Gnoth C, Schuring AN, Friol K, Tiggens J, Mallmann P, Godehardt E: Relevance of anti-Müllerian hormone measurement in routine IVF program. Hum Reprod. 2008, 23: 1359-1365. 10.1093/humrep/den108.CrossRefPubMed
7.
go back to reference Barad DH, Weghofer A, Goyal A, Gleicher N: Age-specific anti-Müllerian hormone (AMH): levels discriminate at each age between poorer and better oocytes yields. Fertil Steril. 2009, 92 (Suppl): S100-1. Barad DH, Weghofer A, Goyal A, Gleicher N: Age-specific anti-Müllerian hormone (AMH): levels discriminate at each age between poorer and better oocytes yields. Fertil Steril. 2009, 92 (Suppl): S100-1.
8.
go back to reference Carlsen SM, Vanky E, Fleming R: Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome. Hum Reprod. 2009, 24: 1732-1738. 10.1093/humrep/dep074.CrossRefPubMed Carlsen SM, Vanky E, Fleming R: Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome. Hum Reprod. 2009, 24: 1732-1738. 10.1093/humrep/dep074.CrossRefPubMed
9.
go back to reference Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, Gaudoin M, Mitchell P, Ambrose P, Fleming R: Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod. 2009, 24: 867-875. 10.1093/humrep/den480.CrossRefPubMed Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, Gaudoin M, Mitchell P, Ambrose P, Fleming R: Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod. 2009, 24: 867-875. 10.1093/humrep/den480.CrossRefPubMed
10.
go back to reference Gleicher N, Weghofer A, Barad DH: A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone. Fertil Steril. 2009, 91: 1700-1706. 10.1016/j.fertnstert.2008.01.098.CrossRefPubMed Gleicher N, Weghofer A, Barad DH: A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone. Fertil Steril. 2009, 91: 1700-1706. 10.1016/j.fertnstert.2008.01.098.CrossRefPubMed
11.
go back to reference Gleicher N, Weghofer A, Oktay K, Barad DH: The FMR1 (fragile X) gene serves as predictor of response to ovarian stimulation. Reprod Sciences. 2009, 16: 462-467. 10.1177/1933719108328617.CrossRef Gleicher N, Weghofer A, Oktay K, Barad DH: The FMR1 (fragile X) gene serves as predictor of response to ovarian stimulation. Reprod Sciences. 2009, 16: 462-467. 10.1177/1933719108328617.CrossRef
12.
go back to reference Gleicher N, Weghofer A, Oktay K, Barad DH: Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: A new infertility test?. Acta Scand Obstet Gynecol. 2009, 88: 1024-1030. 10.1080/00016340903171058.CrossRef Gleicher N, Weghofer A, Oktay K, Barad DH: Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: A new infertility test?. Acta Scand Obstet Gynecol. 2009, 88: 1024-1030. 10.1080/00016340903171058.CrossRef
13.
go back to reference Gleicher N, Weghofer A, Barad DH: Triple CGG counts on the FMR1 (fragile X) gene vary between races/ethnicities based on distribution, but not based on normal range and median. Fertil Steril. 2009, 92 (Suppl): S12- Gleicher N, Weghofer A, Barad DH: Triple CGG counts on the FMR1 (fragile X) gene vary between races/ethnicities based on distribution, but not based on normal range and median. Fertil Steril. 2009, 92 (Suppl): S12-
14.
go back to reference Gleicher N, Weghofer A, Oktay K, Barad DH: Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulation ovarian ageing. Reprod Biomed Online. 2010, doi.10.1016/rbmo 2010.02.020 Gleicher N, Weghofer A, Oktay K, Barad DH: Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulation ovarian ageing. Reprod Biomed Online. 2010, doi.10.1016/rbmo 2010.02.020
15.
go back to reference Kevenaar ME, Meerasahib MF, Kramer P, van de Lang-Born MBN, de Jong FH, Groome NP, Themmen APN, Visser JA: Serum AMH levels reflect the size of the primordial follicle pool in mice. Endocrinology. 2006, 147: 3228-3224. 10.1210/en.2005-1588.CrossRefPubMed Kevenaar ME, Meerasahib MF, Kramer P, van de Lang-Born MBN, de Jong FH, Groome NP, Themmen APN, Visser JA: Serum AMH levels reflect the size of the primordial follicle pool in mice. Endocrinology. 2006, 147: 3228-3224. 10.1210/en.2005-1588.CrossRefPubMed
16.
go back to reference Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G: Basal level of anti-Müllerian hormone is associated with oocytes quality in stimulated cycles. Hum Reprod. 2006, 21: 2022-2026. 10.1093/humrep/del127.CrossRefPubMed Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G: Basal level of anti-Müllerian hormone is associated with oocytes quality in stimulated cycles. Hum Reprod. 2006, 21: 2022-2026. 10.1093/humrep/del127.CrossRefPubMed
17.
go back to reference Fleming R, Deshpande N, Traynor I, Yates RW: Dynamics of FSH-induced follicular gowth in subfertile women: relationship with age, insulin resistance, oocytes yield and anti-Müllerian hormone. Hum Reprod. 2006, 21: 1436-41. 10.1093/humrep/dei499.CrossRefPubMed Fleming R, Deshpande N, Traynor I, Yates RW: Dynamics of FSH-induced follicular gowth in subfertile women: relationship with age, insulin resistance, oocytes yield and anti-Müllerian hormone. Hum Reprod. 2006, 21: 1436-41. 10.1093/humrep/dei499.CrossRefPubMed
18.
go back to reference Sun W, Stegman BJ, Henne M, Catherino WH, Segars JH: A new approach towards ovarian reserve testing. Fertil Steril. 2008, 90: 2196-2203. 10.1016/j.fertnstert.2007.10.080.PubMedCentralCrossRefPubMed Sun W, Stegman BJ, Henne M, Catherino WH, Segars JH: A new approach towards ovarian reserve testing. Fertil Steril. 2008, 90: 2196-2203. 10.1016/j.fertnstert.2007.10.080.PubMedCentralCrossRefPubMed
19.
go back to reference Broer SL, Mol BWJ, Hendriks D, Broekmans FJM: The role of antimullerian hormone in predicting outcome after IVF: comparison with antral follicle count. Fertil Steril. 2009, 91: 705-715. 10.1016/j.fertnstert.2007.12.013.CrossRefPubMed Broer SL, Mol BWJ, Hendriks D, Broekmans FJM: The role of antimullerian hormone in predicting outcome after IVF: comparison with antral follicle count. Fertil Steril. 2009, 91: 705-715. 10.1016/j.fertnstert.2007.12.013.CrossRefPubMed
20.
go back to reference Knauff EA, Eijkemans MJ, Lambalk CB, ten Kate-Booji MJ, the Dutch Premature Ovarian Failue Consortium: Anti-Müllerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab. 2009, 94: 786-792. 10.1210/jc.2008-1818.CrossRefPubMed Knauff EA, Eijkemans MJ, Lambalk CB, ten Kate-Booji MJ, the Dutch Premature Ovarian Failue Consortium: Anti-Müllerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab. 2009, 94: 786-792. 10.1210/jc.2008-1818.CrossRefPubMed
21.
go back to reference Nelson SM, Yates RW, Fleming R: Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulation cycles-implications for individualization of therapy. Hum Reprod. 2007, 22: 2414-2421. 10.1093/humrep/dem204.CrossRefPubMed Nelson SM, Yates RW, Fleming R: Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulation cycles-implications for individualization of therapy. Hum Reprod. 2007, 22: 2414-2421. 10.1093/humrep/dem204.CrossRefPubMed
22.
go back to reference Singer T, Barad DH, Weghofer A, Gleicher N: Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels. Fertil Steril. 2009, 91: 261-10.1016/j.fertnstert.2008.03.034.CrossRef Singer T, Barad DH, Weghofer A, Gleicher N: Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels. Fertil Steril. 2009, 91: 261-10.1016/j.fertnstert.2008.03.034.CrossRef
23.
go back to reference Toner JP: Modest follicle-stimulating hormone elevations in younger women: wyarn but don't disqualify. Fertil Steril. 2004, 81: 1493-1495. 10.1016/j.fertnstert.2003.11.038.CrossRefPubMed Toner JP: Modest follicle-stimulating hormone elevations in younger women: wyarn but don't disqualify. Fertil Steril. 2004, 81: 1493-1495. 10.1016/j.fertnstert.2003.11.038.CrossRefPubMed
24.
go back to reference Fu YH, Kuhl DP, Pizutti A: Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991, 67: 1047-1058. 10.1016/0092-8674(91)90283-5.CrossRefPubMed Fu YH, Kuhl DP, Pizutti A: Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991, 67: 1047-1058. 10.1016/0092-8674(91)90283-5.CrossRefPubMed
Metadata
Title
Can egg donor selection be improved? - a pilot study
Authors
Norbert Gleicher
Andrea Weghofer
David H Barad
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2010
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/1477-7827-8-76

Other articles of this Issue 1/2010

Reproductive Biology and Endocrinology 1/2010 Go to the issue